結節性痒疹治療の世界市場レポート 2025年

結節性痒疹治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.1％で21億1,000万米ドルに成長します。予測期間中の成長は、ヘルスケア支出の増加、結節性痒疹に対する認知度の向上、標的治療に対する需要の高まり、研究開発活動の増加、新規治療法の承認増加などに起因すると考えられます。予測期間における主要動向としては、生物学的療法の発展、皮膚疾患の診断アプローチの改善、局所治療製剤の革新、遠隔皮膚科サービスの統合、患者中心の先進的ケアモデルの開発などが挙げられます。

慢性皮膚疾患の有病率の増加は、今後数年間の結節性痒疹治療市場の成長を牽引すると予想されます。慢性皮膚疾患は、長期的または反復的な皮膚障害であり、継続的な管理を必要とすることが多く、患者のQOLに大きな影響を与える可能性があります。このような疾患の増加は、環境汚染物質への曝露が増加したことに起因しており、環境汚染物質は皮膚の天然バリアを損傷し、持続的な炎症を引き起こす可能性があります。結節性痒疹の治療は、継続的なかゆみや皮膚病変の原因となる炎症経路を標的とすることで、慢性皮膚疾患の根本的な原因に対処することに重点を置いています。免疫系の過剰活性を制御することにより、これらの治療法は結節性痒疹患者の症状を効果的に緩和し、生活の質を改善します。例えば、2023年7月、英国の慈善団体であるOffice of Health Economics（OHE）は、痛みを伴う慢性皮膚疾患である膿疱性汗腺炎（HS）は英国で少なくとも20万人が罹患しており、その経済効果は年間38億3,000万ポンド（約43億5,000万円）と推定されると報告しました。したがって、慢性皮膚疾患の発生率の増加が結節性痒疹治療市場の成長に寄与しています。

結節性痒疹治療市場の主要企業は、特定の免疫経路を標的とし、より効果的な症状緩和を目指すモノクローナル抗体を含む革新的な治療法の開拓に注力しています。モノクローナル抗体は、ウイルスを含む有害な病原体と闘う免疫系の自然な能力を複製するように設計された合成分子です。例えば、2024年8月、スイスの製薬会社ガルデルマは、米国食品医薬品局（FDA）が結節性痒疹の成人患者の治療としてネムルビオ（ネモリズマブ）を承認したと発表しました。この承認は、ネムルビオが痒みの強さと皮膚結節に顕著な改善を示したOLYMPIA臨床検査の有望な結果に続くものです。この治療は、結節性痒疹の症状を引き起こす重要な役割を果たすIL-31シグナルを特異的に標的とします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の結節性痒疹治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の結節性痒疹治療市場：成長率分析
• 世界の結節性痒疹治療市場の実績：規模と成長、2019～2024年
• 世界の結節性痒疹治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の結節性痒疹治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の結節性痒疹治療市場：治療法別、実績と予測、2019～2024年、2024～2029年、2034年
• 医薬品
• 凍結療法
• 光線療法
• パルス色素レーザー
• その他の治療法
• 世界の結節性痒疹治療市場：診断別、実績と予測、2019～2024年、2024～2029年、2034年
• 皮膚生検
• 血液検査
• その他
• 世界の結節性痒疹治療市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所投与
• 経口投与
• 非経口投与
• 世界の結節性痒疹治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の結節性痒疹治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• クリニック
• 病院
• その他
• 世界の結節性痒疹治療市場、医薬品のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所コルチコステロイド
• 抗ヒスタミン薬
• 免疫抑制剤
• 神経調節薬
• 生物学的療法
• 世界の結節性痒疹治療市場、凍結療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 液体窒素の適用
• スプレー凍結技術
• 凍結プローブ療法
• 世界の結節性痒疹治療市場、光線療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 狭帯域紫外線B（NB-UVB）
• 広帯域紫外線B（BB-UVB）
• ソラレンプラスウルトラバイオレット A（PUVA）
• 世界の結節性痒疹治療市場、パルス色素レーザーのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 585ナノメートル（nm）波長療法
• 595ナノメートル（nm）波長療法
• 世界の結節性痒疹治療市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 行動療法
• 鍼
• エモリエント剤と保湿剤
• 外科的切除

第7章 地域別・国別分析

• 世界の結節性痒疹治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の結節性痒疹治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 結節性痒疹治療市場：競合情勢
• 結節性痒疹治療市場：企業プロファイル
  • Roche Holding AG
  • Sanofi S.A.
  • Amgen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Galderma S.A

第31章 その他の大手企業と革新的企業

• Incyte Corporation
• LEO Pharma A/S
• Almirall S.A.
• Maruho Co. Ltd.
• VYNE Therapeutics Inc.
• Kiniksa Pharmaceuticals Ltd.
• Trevi Therapeutics Inc.
• Healio
• Keymed Biosciences Inc.
• MyHealthTeam
• Shanghai SIGMA High-tech Co. Ltd.
• Celgene Corporation
• Dermatology Treatment and Research Center
• Hightower Clinical
• Celldex Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 結節性痒疹治療市場、2029年：新たな機会を提供する国
• 結節性痒疹治療市場、2029年：新たな機会を提供するセグメント
• 結節性痒疹治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Prurigo nodularis treatment involves various medical approaches aimed at relieving the persistent itching and skin lesions associated with this inflammatory condition. The primary goal is to break the cycle of scratching that worsens the symptoms. Treatment focuses on soothing itching, promoting the healing of nodules, and improving the overall well-being of the patient.

The main types of prurigo nodularis treatment include medications, cryotherapy, phototherapy, pulsed dye laser, and other therapies. Medications are used to alleviate itching, reduce inflammation, and modulate the immune response. Diagnosis typically involves skin biopsies, blood tests, and other methods. Treatments are administered through various routes, including topical, oral, and parenteral administration. These treatments are distributed through multiple channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by different end-users, including clinics, hospitals, and others.

The prurigo nodularis treatment market research report is one of a series of new reports from The Business Research Company that provides prurigo nodularis treatment market statistics, including the prurigo nodularis treatment industry global market size, regional shares, competitors with the prurigo nodularis treatment market share, detailed prurigo nodularis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the prurigo nodularis treatment industry. This prurigo nodularis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The prurigo nodularis treatment market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.73 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to increased investment in dermatology research, a rising demand for personalized medicine, a growing pipeline of novel therapies, more regulatory approvals for treatment options, and an increased use of teledermatology services.

The prurigo nodularis treatment market size is expected to see strong growth in the next few years. It will grow to $2.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth during the forecast period can be attributed to increasing healthcare expenditure, rising awareness of prurigo nodularis, a growing demand for targeted therapies, an increase in research and development activities, and more approvals of novel treatments. Key trends in the forecast period include advancements in biologic therapies, improved diagnostic approaches for skin conditions, innovations in topical treatment formulations, integration of teledermatology services, and the development of advanced patient-centric care models.

The increasing prevalence of chronic skin conditions is expected to drive the growth of the prurigo nodularis treatment market in the coming years. Chronic skin conditions are long-term or recurring skin disorders that often require ongoing management and can significantly impact a person's quality of life. The rise in these conditions is attributed to higher exposure to environmental pollutants, which can damage the skin's natural barrier and cause persistent inflammation. Prurigo nodularis treatments focus on addressing the underlying causes of chronic skin conditions by targeting inflammatory pathways responsible for ongoing itching and skin lesions. By regulating immune system overactivity, these therapies effectively alleviate symptoms and improve quality of life for patients with prurigo nodularis. For example, in July 2023, the Office of Health Economics (OHE), a UK-based charity, reported that hidradenitis suppurativa (HS), a painful chronic skin disease, affects at least 200,000 people in the UK, with an estimated economic impact of £3.83 billion ($4.35 billion) annually. Therefore, the increasing incidence of chronic skin conditions is contributing to the growth of the prurigo nodularis treatment market.

Leading companies in the prurigo nodularis treatment market are concentrating on developing innovative therapies, including monoclonal antibodies, which aim to target specific immune pathways and offer more effective symptom relief. Monoclonal antibodies are synthetic molecules designed to replicate the immune system's natural ability to combat harmful pathogens including viruses. For example, in August 2024, the Switzerland-based pharmaceutical company Galderma announced that the U.S. Food and Drug Administration (FDA) had approved Nemluvio (nemolizumab) for the treatment of adult patients with prurigo nodularis. This approval followed promising results from the OLYMPIA clinical trials, in which Nemluvio showed notable improvements in itch intensity and skin nodules. The treatment specifically targets IL-31 signaling, which plays a crucial role in driving the symptoms of prurigo nodularis.

In December 2022, MyHealthTeam, a U.S.-based provider of treatment solutions for prurigo nodularis, teamed up with Arcutis Biotherapeutics to introduce MySebDermTeam, a new social platform designed to support individuals living with seborrheic dermatitis. The partnership aims to tackle issues including underdiagnosis and limited access to reliable information, particularly within underserved communities, by providing trusted connections and expert advice to help speed up diagnosis and treatment. Arcutis Biotherapeutics is a US-based biopharmaceutical company focused on developing and commercializing therapies for dermatological conditions.

Major players in the prurigo nodularis treatment market are Roche Holding AG, Sanofi S.A., Amgen Inc., Regeneron Pharmaceuticals Inc., Galderma S.A., Incyte Corporation, LEO Pharma A/S, Almirall S.A., Maruho Co. Ltd., VYNE Therapeutics Inc., Kiniksa Pharmaceuticals Ltd., Trevi Therapeutics Inc., Healio, Keymed Biosciences Inc., MyHealthTeam, Shanghai SIGMA High-tech Co. Ltd., Celgene Corporation, Dermatology Treatment and Research Center, Hightower Clinical, Celldex Therapeutics Inc., Psoriasis Treatment Center of Central New Jersey, and Skin Care Research.

North America was the largest region in the prurigo nodularis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in prurigo nodularis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prurigo nodularis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prurigo nodularis treatment market consists of revenues earned by entities by providing services such as medical consultation, psychological support, wound care, and bandaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The prurigo nodularis treatment market also includes sales of patch test kits, punch biopsy tools, and injectable monoclonal antibodies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prurigo Nodularis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prurigo nodularis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prurigo nodularis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prurigo nodularis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medication; Cryotherapy; Phototherapy; Pulsed Dye Laser; Other Treatments
• 2) By Diagnosis: Skin Biopsy; Blood Tests; Other Diagnosis
• 3) By Route Of Administration: Topical Administration; Oral Administration; Parenteral Administration
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End-Users: Clinic; Hospital; Other End-Users
• Subsegments:
• 1) By Medication: Topical Corticosteroids; Antihistamines; Immunosuppressants; Neuromodulators; Biologic Therapies
• 2) By Cryotherapy: Liquid Nitrogen Application; Spray-Freezing Techniques; Cryoprobe Therapy
• 3) By Phototherapy: Narrowband Ultraviolet B (NB-UVB); Broadband Ultraviolet B (BB-UVB); Psoralen Plus Ultraviolet A (PUVA)
• 4) By Pulsed Dye Laser: 585 Nanometer (nm) Wavelength Therapy; 595 Nanometer (nm) Wavelength Therapy
• 5) By Other Treatments: Behavioral Therapy; Acupuncture; Emollients and Moisturizers; Surgical Excision
• Companies Mentioned: Roche Holding AG; Sanofi S.A.; Amgen Inc.; Regeneron Pharmaceuticals Inc.; Galderma S.A
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prurigo Nodularis Treatment Market Characteristics

3. Prurigo Nodularis Treatment Market Trends And Strategies

4. Prurigo Nodularis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Prurigo Nodularis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prurigo Nodularis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prurigo Nodularis Treatment Market Growth Rate Analysis
• 5.4. Global Prurigo Nodularis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prurigo Nodularis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prurigo Nodularis Treatment Total Addressable Market (TAM)

6. Prurigo Nodularis Treatment Market Segmentation

• 6.1. Global Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Cryotherapy
• Phototherapy
• Pulsed Dye Laser
• Other Treatments
• 6.2. Global Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Biopsy
• Blood Tests
• Other Diagnosis
• 6.3. Global Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Administration
• Oral Administration
• Parenteral Administration
• 6.4. Global Prurigo Nodularis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Prurigo Nodularis Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinic
• Hospital
• Other End-Users
• 6.6. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Antihistamines
• Immunosuppressants
• Neuromodulators
• Biologic Therapies
• 6.7. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Cryotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Nitrogen Application
• Spray-Freezing Techniques
• Cryoprobe Therapy
• 6.8. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Narrowband Ultraviolet B (NB-UVB)
• Broadband Ultraviolet B (BB-UVB)
• Psoralen Plus Ultraviolet A (PUVA)
• 6.9. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Pulsed Dye Laser, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 585 Nanometer (nm) Wavelength Therapy
• 595 Nanometer (nm) Wavelength Therapy
• 6.10. Global Prurigo Nodularis Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Behavioral Therapy
• Acupuncture
• Emollients and Moisturizers
• Surgical Excision

7. Prurigo Nodularis Treatment Market Regional And Country Analysis

• 7.1. Global Prurigo Nodularis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prurigo Nodularis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prurigo Nodularis Treatment Market

• 8.1. Asia-Pacific Prurigo Nodularis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prurigo Nodularis Treatment Market

• 9.1. China Prurigo Nodularis Treatment Market Overview
• 9.2. China Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prurigo Nodularis Treatment Market

• 10.1. India Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prurigo Nodularis Treatment Market

• 11.1. Japan Prurigo Nodularis Treatment Market Overview
• 11.2. Japan Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prurigo Nodularis Treatment Market

• 12.1. Australia Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prurigo Nodularis Treatment Market

• 13.1. Indonesia Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prurigo Nodularis Treatment Market

• 14.1. South Korea Prurigo Nodularis Treatment Market Overview
• 14.2. South Korea Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prurigo Nodularis Treatment Market

• 15.1. Western Europe Prurigo Nodularis Treatment Market Overview
• 15.2. Western Europe Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prurigo Nodularis Treatment Market

• 16.1. UK Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prurigo Nodularis Treatment Market

• 17.1. Germany Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prurigo Nodularis Treatment Market

• 18.1. France Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prurigo Nodularis Treatment Market

• 19.1. Italy Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prurigo Nodularis Treatment Market

• 20.1. Spain Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prurigo Nodularis Treatment Market

• 21.1. Eastern Europe Prurigo Nodularis Treatment Market Overview
• 21.2. Eastern Europe Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prurigo Nodularis Treatment Market

• 22.1. Russia Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prurigo Nodularis Treatment Market

• 23.1. North America Prurigo Nodularis Treatment Market Overview
• 23.2. North America Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prurigo Nodularis Treatment Market

• 24.1. USA Prurigo Nodularis Treatment Market Overview
• 24.2. USA Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prurigo Nodularis Treatment Market

• 25.1. Canada Prurigo Nodularis Treatment Market Overview
• 25.2. Canada Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prurigo Nodularis Treatment Market

• 26.1. South America Prurigo Nodularis Treatment Market Overview
• 26.2. South America Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prurigo Nodularis Treatment Market

• 27.1. Brazil Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prurigo Nodularis Treatment Market

• 28.1. Middle East Prurigo Nodularis Treatment Market Overview
• 28.2. Middle East Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prurigo Nodularis Treatment Market

• 29.1. Africa Prurigo Nodularis Treatment Market Overview
• 29.2. Africa Prurigo Nodularis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prurigo Nodularis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prurigo Nodularis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prurigo Nodularis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Prurigo Nodularis Treatment Market Competitive Landscape
• 30.2. Prurigo Nodularis Treatment Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Galderma S.A Overview, Products and Services, Strategy and Financial Analysis

31. Prurigo Nodularis Treatment Market Other Major And Innovative Companies

• 31.1. Incyte Corporation
• 31.2. LEO Pharma A/S
• 31.3. Almirall S.A.
• 31.4. Maruho Co. Ltd.
• 31.5. VYNE Therapeutics Inc.
• 31.6. Kiniksa Pharmaceuticals Ltd.
• 31.7. Trevi Therapeutics Inc.
• 31.8. Healio
• 31.9. Keymed Biosciences Inc.
• 31.10. MyHealthTeam
• 31.11. Shanghai SIGMA High-tech Co. Ltd.
• 31.12. Celgene Corporation
• 31.13. Dermatology Treatment and Research Center
• 31.14. Hightower Clinical
• 31.15. Celldex Therapeutics Inc.

32. Global Prurigo Nodularis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prurigo Nodularis Treatment Market

34. Recent Developments In The Prurigo Nodularis Treatment Market

35. Prurigo Nodularis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Prurigo Nodularis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prurigo Nodularis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prurigo Nodularis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer